VRB-101

DRUG3 trials

Sponsors

Verdiva Bio Dev Limited

Conditions

ObesityOverweightWeight Maintenance

Phase 1

A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

RecruitingNCT07628127

Verdiva Bio Dev LimitedObesity, Overweight

Start: 2026-07-06End: 2028-03-01Target: 336Updated: 2026-08-11

Phase 2

A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

CompletedNCT07281937

Verdiva Bio Dev LimitedObesity, Overweight

Start: 2025-11-25End: 2026-07-23Updated: 2026-08-17

A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Active, not recruitingNCT07553299

Verdiva Bio Dev LimitedObesity, Overweight, Weight Maintenance

Start: 2026-06-12End: 2026-12-31Target: 120Updated: 2026-08-04